These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
121 related items for PubMed ID: 9089816
1. A strong thrombin-inhibitory prourokinase derivative with sequence elements from hirudin and the human thrombin receptor. Wnendt S, Janocha E, Steffens GJ, Strassburger W. Protein Eng; 1997 Feb; 10(2):169-73. PubMed ID: 9089816 [Abstract] [Full Text] [Related]
2. Construction and structure-activity relationships of chimeric prourokinase derivatives with intrinsic thrombin-inhibitory potential. Wnendt S, Janocha E, Schneider J, Steffens GJ. Protein Eng; 1996 Feb; 9(2):213-23. PubMed ID: 9005443 [Abstract] [Full Text] [Related]
4. Modular design of a novel chimeric protein with combined thrombin inhibitory activity and plasminogen-activating potential. Wirsching F, Luge C, Schwienhorst A. Mol Genet Metab; 2002 Mar; 75(3):250-9. PubMed ID: 11914037 [Abstract] [Full Text] [Related]
5. A novel chimaeric derivative of saruplase, rscu-PA-40 kDA/Hir, binds to thrombin and exerts thrombus-specific fibrinolysis in arterial and venous thrombosis in dogs. Schneider J, Hauser R, Hennies HH, Korioth J, Steffens G, Wnendt S. Thromb Haemost; 1997 Mar; 77(3):535-9. PubMed ID: 9066007 [Abstract] [Full Text] [Related]
6. The region of the thrombin receptor resembling hirudin binds to thrombin and alters enzyme specificity. Liu LW, Vu TK, Esmon CT, Coughlin SR. J Biol Chem; 1991 Sep 15; 266(26):16977-80. PubMed ID: 1654318 [Abstract] [Full Text] [Related]
8. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin. Johnson PH, Sze P, Winant RC, Hudson D, Underhill P, Lazar JB, Olsen C, Almquist R. Haemostasis; 1991 Apr 15; 21 Suppl 1():41-8. PubMed ID: 1894196 [Abstract] [Full Text] [Related]
9. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments. Chang JY. J Biol Chem; 1990 Dec 25; 265(36):22159-66. PubMed ID: 2266119 [Abstract] [Full Text] [Related]
10. Rational design of hirulog-type inhibitors of thrombin. Egner U, Hoyer GA, Schleuning WD. J Comput Aided Mol Des; 1994 Oct 25; 8(5):479-90. PubMed ID: 7876896 [Abstract] [Full Text] [Related]
11. Design of potent bivalent thrombin inhibitors based on hirudin sequence: incorporation of nonsubstrate-type active site inhibitors. Tsuda Y, Cygler M, Gibbs BF, Pedyczak A, Féthière J, Yue SY, Konishi Y. Biochemistry; 1994 Dec 06; 33(48):14443-51. PubMed ID: 7981204 [Abstract] [Full Text] [Related]
16. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding. Ayala YM, Vindigni A, Nayal M, Spolar RS, Record MT, Di Cera E. J Mol Biol; 1995 Nov 10; 253(5):787-98. PubMed ID: 7473752 [Abstract] [Full Text] [Related]
17. Structure-function relationships of the C-terminal functional domain of hirudin and its variants. Krstenansky JL, Mao SJ. Blood Coagul Fibrinolysis; 1991 Feb 10; 2(1):91-6. PubMed ID: 1773003 [Abstract] [Full Text] [Related]
18. Domain-domain interactions in hybrids of tissue-type plasminogen activator and urokinase-type plasminogen activator. Bakker AH, Nieuwenbroek NM, Verheijen JH. Protein Eng; 1995 Dec 10; 8(12):1295-1302. PubMed ID: 8869642 [Abstract] [Full Text] [Related]
19. Interaction of the N-terminal region of hirudin with the active-site cleft of thrombin. Betz A, Hofsteenge J, Stone SR. Biochemistry; 1992 May 19; 31(19):4557-62. PubMed ID: 1581311 [Abstract] [Full Text] [Related]
20. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation. De Filippis V, Colombo G, Russo I, Spadari B, Fontana A. Biochemistry; 2002 Nov 19; 41(46):13556-69. PubMed ID: 12427016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]